Manufacturer Removes Remaining Stocks of Trasylol
Access Limited to Investigational Use Background: On Nov. 5, 2007, the U.S. Food and Drug Administration announced that Bayer Pharmaceuticals Corp. agreed...

Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; Vyvanse Demand on Track
...coupons, wholesaler discounts and rebates, which will trend over time to approximately 28% of product sales before sales deductions. Launch stocks of $55.9 million (before sales deductions) were shipped to wholesalers in June 2007, with a further $1.9 million shipped in July 2007. Sales of...

IFRS Information - First Half of 2007
...and believes that the settlements are in compliance with all applicable laws. VYVANSE VYVANSE was launched in the US in June 2007. Launch stocks of $55.9 million (before sales deductions) were shipped to wholesalers during June 2007. In accordance with IFRS, sales of these launch stocks have...

Shire plc: 2007 Guidance Upgraded as Revenue Growth Accelerates
...with all applicable laws. VYVANSE - ADHD VYVANSE was launched in the US in June 2007 following receipt of required regulatory approvals. Launch stocks of US$55.9 million (before sales deductions) were shipped to wholesalers during June 2007. In accordance with US GAAP, sales of these launch stocks...

Shire plc: IFRS Results for the Year Ending December 31, 2007
...wholesaler discounts and rebates, which are expected over time to be approximately 28% of product sales before sales deductions. All initial launch stocks of VYVANSE totaling US$57.8 million were recognised into revenue during the year to December 31, 2007. DAYTRANA - ADHD Product sales for the year...

HealthShares Announces Changes to the HealthShares Infectious Disease, Respiratory/Pulmonary, Cancer, and Composite Indexes
...infectious disease, etc.) and the development of medical devices (e.g. orthopedic repair, cardio devices, etc.). Each ETF tracks an index of 22-25 stocks and 2 offers institutional and individual investors a more precise financial instrument that leverages the potential of healthcare investing while...

Scientists Create Breast Tumor Stem Cells
...independent scientists is critical for scientific progress, so it's important for different labs to have the choice to use similar or identical cell stocks,' he said. 'If two labs have different results, it is not possible to know whether this is a real difference or simply because different labs are...

EMEA Recommends Information on Lung Cancer Cases to Be Included in Exubera Product Information
There have been a total of seven cases of lung cancer diagnosed in patients who have taken Exubera. Five of these cases were in studies comparing Exubera...

Double-digit increase in sales, operating profit1 and Core EPS
...cases of the new type of influenza were reported, Roche responded immediately to the WHOs request to supply Mexico and 71 other countries with the stocks of Tamiflu that had previously been donated and stored in anticipation of a pandemic situation. The same month Roche announced that it was making...

Health Highlights: May 15, 2008
...Relenza, BBC News reported. The study appears in the journal Nature. 'In order not to be outflanked by the virus, it will be necessary to have stocks of both existing drugs,' said research team leader Dr. Steve Gamblin, BBC News reported. 'There is a huge imperative to develop further drugs and...

Having trouble finding what you want?

• Try browsing our A-Z List of Drug Names or our Medical Encyclopedia.
• Try posting your query on the Drugs.com Community Discussion Boards
• Drug Interactions Checker provides detailed information on drug-drug and drug-food interactions.
• Pill Identifier will help you identify an unknown pill by imprint code or shape/color.
• Image Search is helpful if you want to know what a certain pill looks like.
• News, FDA Approvals or In The Pipeline may help if the drug you are looking for is a new drug.